An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

By sjmartinez • June 20, 2024

Shah A, Tabibian J, Buness C, Holtmann GJ. An 'Adaptive Treatment Strategy' for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08497-4. Epub ahead of print. PMID: 38896361.

Tags: Adaptive treatment strategy, Digestive Diseases, Olive View DoM, Oral vancomycin, Orphan disease, Primary sclerosing cholangitis, Publications, rare disease, Therapeutic decision-making

ZIP8 A391T Crohn’s Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and Inflammation

Yang JC, Zhao M, Chernikova D, Arias-Jayo N, Zhou Y, Situ J, Gutta A, Chang C, Liang F, Lagishetty V, Jacobs JP. ZIP8 A391T Crohn's[...]

Correlation of needle biopsy-acquired histopathologic grade of hepatocellular carcinoma with outcomes after thermal ablation

Chiang J, Raman SS, Ramakrishnan A, Keshavarz P, Sayre J, McWilliams JP, Finn RS, Agopian VG, Choi G, Lu DSK. Correlation of needle biopsy-acquired histopathologic[...]

Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B

Xie Y, Irwin S, Chupina Estrada A, Nelson B, Bullock A, Fontenot L, Feng H, Sun M, Koon HW. Loratadine as an Anti-inflammatory Agent Against[...]